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Introduction
The advent of recombinant DNA technologies has created
unprecedented opportunities for significantly improving the
treatment and prevention of human disease. Recombinant
DNA technology has made it possible to study the molecu-
lar factors that modulate cellular responses to various
metabolic and environmental stresses. Incorporating mole-
cular biology techniques into the research arsenal of the
physician will provide the opportunity to dissect and define
the reversible and irreversible intracellular processes that
give rise to acute respiratory distress syndrome, sepsis,
septic shock, and multiple system organ failure (ie the
major causes of mortality in most respiratory and multidisci-
plinary intensive care units). Primarily, this short review dis-
cusses a specific example of gene expression that has
been studied over the past 20 years, and its relevance to
acute lung injury and sepsis, two of the most common
causes of critical illness.
Acute lung injury is defined as a phenomenon of acute
diffuse lung inflammation. When inflammatory cells are
sequestered and activated in the lung, they release poten-
tially toxic metabolites, proteolytic enzymes, and an array of
cytokines. Survival of patients who have acute respiratory
failure after acute lung injury depends on prompt alveolar
repair. Even when the original inciting factor is controlled,
outcome varies from complete recovery to death. The sur-
vival rate approximates 50% in all major series [1] and the
major determinant of outcome is the failure of other vital
organ systems. Approximately 90% of all deaths occur
within 2–3 weeks of the onset of the syndrome.
Gene expression in the lung during critical
illness
The cellular events involved in lung inflammation, and
organ damage and repair are ultimately controlled at the
molecular level and cannot be fully understood without
consideration of the functions of the relevant genes and
their gene products. It is now widely recognized that
various cellular stimuli mediate their physiologic effects by
the induction of complex intracellular signaling cascades,
which culminate in the activation or induction of a particu-
lar gene or subset of genes. By extension, activation leads
to the synthesis of particular sets of proteins and a conse-
quent change in cellular behavior. Depending on the
nature of the pathologic perturbation, these steps repre-
sent potential targets for interventive maneuvers and novel
therapeutic strategies.
In considering the pathogenesis of organ inflammation and
damage, neutrophils, monocytes, macrophages, and
platelets represent cell populations that are likely to be eti-
ologically relevant and that therefore represent logical cell
populations to assess in relation to altered gene expres-
sion during organ failure. Similarly, epithelial and endothe-
lial cells respond to injury with acute alterations in
mediator generation and surface molecule expression
[2,3], and appear to act in concert with inflammatory cells
to influence the tissue response to injury and inflammatory
stimuli. These interactions in turn are known to induce the
expression of various genes that encode proteins that are
central to coagulation, fibrinolysis, and repair. Among
these proteins, a critical set of molecules that are involvedhttp://ccforum.com/content/4/1/002
in directing the inflammatory response is the family of
cytokine proteins.
Cytokines, a word derived from the Greek terms for ‘cell’
and ‘mover’, are low-molecular-weight glycoproteins that
may act locally in a paracrine or autocrine manner to influ-
ence cell behavior or may act more generally to induce
substantial systemic effects. The locally active cytokines
are often produced by T-lymphocytes, whereas cytokines
produced by macrophages are often active systemically.
Advances in DNA technology have had a major impact on
the identification of specific cytokines and the definition of
their roles in tissue injury. Molecular studies of cytokine
expression have revealed that the induction of marked
increases in the expression of certain cytokines after
tissue injury often correlates with the magnitude of tissue
damage [4]. Among the cytokines that have been particu-
larly well studied in relation to tissue damage [2–5] are
tumor necrosis factor (TNF)-a, interleukin (IL)-1, IL-2, IL-6,
IL-8, interferon-g, transforming growth factor-b, and
platelet-derived growth factor. The influence of these and
other cytokines on a particular cell or cell population may
be greatly influenced by interactions with other cytokines
and other types of regulatory factors. For example, the
combined effects of IL-1, TNF-a, and lipopolysaccharide
are believed to be responsible for the activation of epithe-
lial and endothelial cells during endotoxemia [6]. These
cytokine–cellular interactions produce acute changes in
cell functioning in response to local injury, and may be
associated with normal growth and repair when function-
ing appropriately, or alternatively with disease pathogene-
sis if cytokine production becomes uncontrolled. Thus,
inappropiate cytokine production and/or cell response to
cytokine stimuli may lead to ongoing inflammation and
chronic disease.
Sepsis represents one of the most challenging problems
in the field of intensive care medicine. Even with the use of
powerful antimicrobial agents, sepsis continues to repre-
sent the most common cause of respiratory failure, multi-
ple system organ dysfunction, and death in patients
admitted into intensive care units. Cumulative experimental
and clinical evidence indicate a major role for cytokine pro-
duction and systemic release in sepsis-induced inflamma-
tory responses. Thus, blocking cytokine activation and/or
pharmacologic effects with specific cytokine-receptor
antagonists represents a logical strategy for the treatment
or attenuation of sepsis-related inflammation [2–7].
Although strategies that facilitate selective downregulation
of the effects of specific cytokines would be particularly
attractive from the therapeutic perspective, achieving this
objective is far from straightforward, because the effects
of specific cytokine inhibition in vivo have proved to be
extremely unpredictable. For example, despite data from
animal studies that show a dramatic efficacy of antibodies
against endotoxin and TNF, and IL-1 receptor antagonist
in the treatment of sepsis [7], corresponding beneficial
effects have not been observed in recent human trials
[8–10]. Accordingly, it appears that information concern-
ing cytokine biology will need to be considerably improved
before contemplating the development of a ‘magic bullet’
that will attenuate inflammatory responses during organ
injury and prevent organ dysfunction.
Heat shock response and heat shock protein
gene expression
From bacteria to humans
The eukaryotic cell response to many potentially deleteri-
ous exposures is remarkably similar to that of prokaryotic
cells. This similarity is particularly well exemplified by the
so-called heat-shock response [11], a response to stress
that involves the rapid induction of a set of highly con-
served genes that encode heat shock proteins (HSPs).
The heat shock response has been observed in virtually all
organisms, including plants and bacteria, as well as inver-
tebrates and vertebrates. Mammalian cells have been
shown to synthesize HSPs after a brief period of hyper-
thermia (temperatures 3–5°C above normal body temper-
ature), but the genes that encode HSPs can also be
induced by a variety of other stimuli, including environmen-
tal modifications, such as prolonged ischemia, sodium
arsenite, ethanol, salicylates, and viral infections, and
agents that affect cell cycle [11]. HSPs may be induced
directly by such agents, or indirectly by virtue of increased
expression of other proteins that in turn provoke HSP
gene expression. Thus, for example, increases in HSP
expression in injured cardiac muscle cells have been
linked to increases in TNF-a and IL-1 production [12].
HSPs are classified into five protein families on the basis of
molecular mass. These include the large molecular weight
HSPs (100kDa); the HSP-90 family; the highly conserved
HSP-70 family, which represents the most prominent
eukaryotic group of HSPs; the HSP-60 family, members of
which are found in bacteria, chloroplasts, and mitochon-
dria; and the small HSP family, members of which are
expressed predominantly in plants. Comparison of the
sequences of the respective heat shock genes from bacte-
ria, plants, flies, and humans have indicated these genes to
be among the most highly conserved proteins in nature. In
addition to this structural conservation, these genes are
also remarkable in their capacity to be rapidly induced in
response to a broad spectrum of stimuli. At least 10
HSP-70 related genes have been found in the human cells,
some of which map to between the complement and TNF-a
and TNF-b genes on chromosome 6 [13].
The HSPs appear to manifest many diverse functions. It
has been suggested, for example, that members of the
HSP-70 family act in the protection of cellular damage by
binding to denatured or abnormal proteins after heat
shock, thereby preventing protein aggregation [14].Critical Care    Vol 4 No 1 Villar
Perhaps the most compelling argument that HSPs have
protective functions is the phenomenon of thermotoler-
ance [11–14]. Thermotolerance represents a property of
all living cells and refers to the capacity of cells to survive
or recover from normally lethal exposures to abrupt, severe
heat shock or stress conditions if, before the lethal stress,
the cells are exposed to milder or shorter periods of
heat/stress conditions. Such ‘tolerizing’ to cellular stress
has been shown to reduce the extend of heat-induced
central nervous system injury markedly [15]. Although the
mechanism for HSP-mediated cytoprotection is not under-
stood, one possible explanation is that this protective
effect relates to the capacity of HSPs to block the synthe-
sis of cytokines such as IL-1b that play key roles in the
febrile and inflammatory responses to stress [16,17].
Preventing organ injury
Irrespective of the mechanisms by which the stress
response provides cytoprotection, the capacity of HSPs
to subserve this function is of considerable interest from
the perspective of elucidating the pathophysiology of
organ damage and dysfunction. Accordingly, a number of
recent studies have addressed the question regarding
whether the induction of the stress response might
protect animals against subsequent injury [18–22]. Our
group [19–22] has examined the effects of the induction
of the heat shock response by whole-body hyperthermia in
attenuating lung damage and outcome in different experi-
mental models of direct and indirect lung injury. Those
studies demonstrated that a brief exposure of experimen-
tal animals to transient hyperthermia, resulting in HSP-72
protein accumulation in the rat lung, attenuated lung
damage and significantly decreased mortality.
To investigate whether the protective effect of the heat
shock response could be generalized to other models of
acute lung injury and could prevent or reduce extrapul-
monary organ injury and death, we chose to study this
effect in a rat model of intra-abdominal sepsis produced by
cecal ligation and perforation [21]. This experimental model
mimics many features of the human septic syndrome, with
the presence of enteric micro-organisms and endotoxin in
the blood. We studied two groups of animals (heated and
unheated), and evaluated survival rates and pathologic
changes in the lung, heart, and liver before and after cecal
perforation, after cecum removal, and at 7 days. At 18h
after perforation, 25% of the unheated animals died,
whereas none of the heated animals died. Seven days after
cecal perforation, the protection was still evident, with 20
and 70% mortalities in the nonstressed and heat-stressed
groups, respectively. In addition, heated animals showed
lessed histologic evidence of lung and liver damage.
Because whole-body warming could be associated with a
number of nonspecific mechanisms that are unrelated to
the induction of the heat shock response, Ribeiro et al [22]
used sodium arsenite as a nonthermal means to induce the
heat shock response and examined whether this could also
provide protection in the same model of intra-abdominal
sepsis. Following a single intravenous injection of sodium
arsenite, HSP-72 was detected in the lungs, with a peak
between 18 and 24h after the insult. Administration of
6mg/kg sodium arsenite 18h before performing cecal liga-
tion and perforation was associated with a marked
decrease in mortality at 18 and 24h after sepsis. The pro-
tection in the sodium arsenite-treated animals appeared to
follow the time course of HSP-72 protein levels.
All of these studies support the hypothesis that HSPs are
cytoprotective in vivo. The mechanisms by which the heat
shock response might provide cytoprotection are not
known. Ribeiro et al [23] have demonstrated recently, in
endotoxin-stimulated alveolar macrophages, that HSP-72
coprecipitated with TNF-a from cells that had received
stress treatment (heat stress and sodium arsenite) before
endotoxin exposure. This finding suggests that HSPs may
participate in post-translational control of TNF-a release,
making HSPs responsible for decreased TNF-a release by
binding TNF-a intracellularly and preventing its release
from macrophages. Therefore, HSPs determine whether
TNF-a is released from the cell or is sent to the lysosomal
machinery for degradation.
Deshpande et al [24] reported in the present issue of Crit-
ical Care that the induction of heat shock response,
before sepsis, markedly decreased lactate concentration
in plasma in septic rats. Lactic acidosis develops as a
result of organ hypoperfusion. Several published clinical
studies during the 1970s and 1980s showed a correlation
between high levels of lactate and poor outcome in
patients with sepsis and septic shock. By contrast, low
levels of lactate and/or an ability to increase lactate clear-
ance has been associated with good prognosis. Although
the mechanisms by which the induction of the heat shock
response might improve organ perfusion and attenuate
organ damage are not fully understood, it has been
demonstrated that the heat shock response inhibits
cytokine-mediated expression of inducible nitric oxide syn-
thase [25]. As Deshpande et al have pointed out [24],
organ protection may depend of the degree and duration
of the heat stress. Although a mild stress induces a pro-
tective response, a more potent stress stimulus induces
apoptosis, and an even stronger one leads to necrosis.
Conclusion
A further understanding of the role of the heat shock
response might allow for the development of rational phar-
macologic agents and to make them potential targets for
therapeutic interventions. Future research could focus on
novel strategies to activate the HSP genes, as a potential
therapy for sepsis, acute lung injury, and other critical care
conditions.http://ccforum.com/content/4/1/002
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